We are de-risking biomedical innovation, turning biomedical knowledge into social and economic value.
More than three decades later, we remain committed in pursuit of pharmaceutical innovation, providing high quality products and striving to deliver superior business results.
The patient is at the heart of what we do, making decisions regarding biometric innovation is usually a complicated and chaotic procedure as it consists of various product options, various facets to ascertain these on, and multiple evaluations at all levels.
Discover our therapeutic areas, where we continuously invest to innovate and deliver therapeutic solutions for patient’s benefit.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
13
Aug 2026
Public health policies are commonly evaluated by their financial costs and expected outcomes. However, policy decisions must also be supported by strong evidence, political feasibility, effective implementation, and public trust to achieve lasting public health benefits.
13
Aug 2026
Children born very preterm were more likely than term-born children to screen positive for autism risk at age 5 using the Social Communication Questionnaire. Among very preterm children, cerebellar abnormalities at term-equivalent age and moderate-to-severe histologic chorioamnionitis were independently associated with higher autism screening risk, alongside male sex and higher social risk.
13
Aug 2026
A seven-day intensive longitudinal study of 106 university students found little evidence that higher-than-usual daytime stress predicted poorer sleep that night. In contrast, better-than-usual subjective sleep was followed by lower perceived stress the next day, while objective sleep associations were generally weak and uncertain.
13
Aug 2026
Researchers from WEHI (Melbourne, Australia) have discovered a new way to help prevent malaria that could one day transform mosquito bites from a source of deadly infection into immunity boosters against the disease.